Scotia Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$129K	Buy	+14,352	New	+$129K	﹤0.01%	818
2024 Q4	–	Sell	-18,577	Closed	-$141K	–	863
2024 Q3	$141K	Buy	+18,577	New	+$141K	﹤0.01%	794